Cargando…
Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology
Cancer is a fatal disease and the second most cause of death worldwide. Treatment of cancer is a complex process and requires a multi-modality-based approach. Cancer detection and treatment starts with screening/diagnosis and continues till the patient is alive. Screening/diagnosis of the disease is...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501896/ https://www.ncbi.nlm.nih.gov/pubmed/37720353 http://dx.doi.org/10.37349/etat.2023.00153 |
_version_ | 1785106204944498688 |
---|---|
author | Jha, Ashish Kumar Mithun, Sneha Sherkhane, Umeshkumar B. Dwivedi, Pooj Puts, Senders Osong, Biche Traverso, Alberto Purandare, Nilendu Wee, Leonard Rangarajan, Venkatesh Dekker, Andre |
author_facet | Jha, Ashish Kumar Mithun, Sneha Sherkhane, Umeshkumar B. Dwivedi, Pooj Puts, Senders Osong, Biche Traverso, Alberto Purandare, Nilendu Wee, Leonard Rangarajan, Venkatesh Dekker, Andre |
author_sort | Jha, Ashish Kumar |
collection | PubMed |
description | Cancer is a fatal disease and the second most cause of death worldwide. Treatment of cancer is a complex process and requires a multi-modality-based approach. Cancer detection and treatment starts with screening/diagnosis and continues till the patient is alive. Screening/diagnosis of the disease is the beginning of cancer management and continued with the staging of the disease, planning and delivery of treatment, treatment monitoring, and ongoing monitoring and follow-up. Imaging plays an important role in all stages of cancer management. Conventional oncology practice considers that all patients are similar in a disease type, whereas biomarkers subgroup the patients in a disease type which leads to the development of precision oncology. The utilization of the radiomic process has facilitated the advancement of diverse imaging biomarkers that find application in precision oncology. The role of imaging biomarkers and artificial intelligence (AI) in oncology has been investigated by many researchers in the past. The existing literature is suggestive of the increasing role of imaging biomarkers and AI in oncology. However, the stability of radiomic features has also been questioned. The radiomic community has recognized that the instability of radiomic features poses a danger to the global generalization of radiomic-based prediction models. In order to establish radiomic-based imaging biomarkers in oncology, the robustness of radiomic features needs to be established on a priority basis. This is because radiomic models developed in one institution frequently perform poorly in other institutions, most likely due to radiomic feature instability. To generalize radiomic-based prediction models in oncology, a number of initiatives, including Quantitative Imaging Network (QIN), Quantitative Imaging Biomarkers Alliance (QIBA), and Image Biomarker Standardisation Initiative (IBSI), have been launched to stabilize the radiomic features. |
format | Online Article Text |
id | pubmed-10501896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Open Exploration Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-105018962023-09-16 Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology Jha, Ashish Kumar Mithun, Sneha Sherkhane, Umeshkumar B. Dwivedi, Pooj Puts, Senders Osong, Biche Traverso, Alberto Purandare, Nilendu Wee, Leonard Rangarajan, Venkatesh Dekker, Andre Explor Target Antitumor Ther Review Cancer is a fatal disease and the second most cause of death worldwide. Treatment of cancer is a complex process and requires a multi-modality-based approach. Cancer detection and treatment starts with screening/diagnosis and continues till the patient is alive. Screening/diagnosis of the disease is the beginning of cancer management and continued with the staging of the disease, planning and delivery of treatment, treatment monitoring, and ongoing monitoring and follow-up. Imaging plays an important role in all stages of cancer management. Conventional oncology practice considers that all patients are similar in a disease type, whereas biomarkers subgroup the patients in a disease type which leads to the development of precision oncology. The utilization of the radiomic process has facilitated the advancement of diverse imaging biomarkers that find application in precision oncology. The role of imaging biomarkers and artificial intelligence (AI) in oncology has been investigated by many researchers in the past. The existing literature is suggestive of the increasing role of imaging biomarkers and AI in oncology. However, the stability of radiomic features has also been questioned. The radiomic community has recognized that the instability of radiomic features poses a danger to the global generalization of radiomic-based prediction models. In order to establish radiomic-based imaging biomarkers in oncology, the robustness of radiomic features needs to be established on a priority basis. This is because radiomic models developed in one institution frequently perform poorly in other institutions, most likely due to radiomic feature instability. To generalize radiomic-based prediction models in oncology, a number of initiatives, including Quantitative Imaging Network (QIN), Quantitative Imaging Biomarkers Alliance (QIBA), and Image Biomarker Standardisation Initiative (IBSI), have been launched to stabilize the radiomic features. Open Exploration Publishing 2023 2023-08-24 /pmc/articles/PMC10501896/ /pubmed/37720353 http://dx.doi.org/10.37349/etat.2023.00153 Text en © The Author(s) 2023. https://creativecommons.org/licenses/by/4.0/This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Jha, Ashish Kumar Mithun, Sneha Sherkhane, Umeshkumar B. Dwivedi, Pooj Puts, Senders Osong, Biche Traverso, Alberto Purandare, Nilendu Wee, Leonard Rangarajan, Venkatesh Dekker, Andre Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology |
title | Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology |
title_full | Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology |
title_fullStr | Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology |
title_full_unstemmed | Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology |
title_short | Emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology |
title_sort | emerging role of quantitative imaging (radiomics) and artificial intelligence in precision oncology |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501896/ https://www.ncbi.nlm.nih.gov/pubmed/37720353 http://dx.doi.org/10.37349/etat.2023.00153 |
work_keys_str_mv | AT jhaashishkumar emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT mithunsneha emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT sherkhaneumeshkumarb emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT dwivedipooj emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT putssenders emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT osongbiche emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT traversoalberto emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT purandarenilendu emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT weeleonard emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT rangarajanvenkatesh emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology AT dekkerandre emergingroleofquantitativeimagingradiomicsandartificialintelligenceinprecisiononcology |